Comparison between the demographic shift clinical severity and outcome of the first two waves of COVID-19 in pregnancy in a tertiary hospital in India

Int J Gynaecol Obstet. 2023 Nov;163(2):586-593. doi: 10.1002/ijgo.14857. Epub 2023 May 15.

Abstract

Objective: To study and compare the maternal and neonatal outcomes of COVID-19 in pregnancy during the two waves of the pandemic in India.

Methods: This observational, retrospective cohort study on pregnant women with SARS-CoV-2 infection was conducted in a 2700-bed tertiary referral center in South India from March 1, 2020 to June 30 2021. The clinical presentation, severity, and maternal and neonatal outcomes of COVID-19 were compared between the two waves.

Results: A total of 623 pregnant women tested positive for SARS-CoV-2 infection in our institute; 379 (60.8%) were diagnosed during the first wave and 244 (39.2%) in the second wave. Most of the affected women (81.1%) were in their third trimester. Maternal mortality rate was 823 per 100 000 live births. Composite maternal outcome (increasing requirement for ventilation, pulmonary embolism, disease progression) were more pronounced during the second wave (2.1% vs 6.1%). Between the two waves, both maternal (1 vs 3; P = 0.162) and perinatal (3.2% vs 6.7%; P = 0.065) deaths were higher during the second wave. The cesarean section rate was high during the first wave (48% vs 32.4%; P < 0.001). Preterm births were comparable between the two waves (19.5% vs 22%; P < 0.500).

Conclusion: The women presented with more severe illness during the second wave of COVID-19. There was higher perinatal mortality, but the maternal mortality was similar between the two waves.

Keywords: COVID-19; SARS-CoV-2; first wave; maternal outcomes; perinatal outcomes; pregnancy; second wave.

Publication types

  • Observational Study

MeSH terms

  • COVID-19* / epidemiology
  • Cesarean Section
  • Female
  • Humans
  • India / epidemiology
  • Infant, Newborn
  • Perinatal Mortality
  • Pregnancy
  • Pregnancy Complications, Infectious* / diagnosis
  • Pregnancy Complications, Infectious* / epidemiology
  • Pregnancy Outcome
  • Retrospective Studies
  • SARS-CoV-2
  • Tertiary Care Centers

Substances

  • P 500